Key hire
Avecho moves to deepen global partnering push as CBD insomnia program advances
Avecho Biotechnology brings in a former CSL dealmaking executive as a consultant to help license its Phase 3 CBD insomnia capsule internationally.
Company
Every investor coverage indicates participated in a round Hospira raised.
Companies Hospira acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Hospira. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Avecho Biotechnology brings in a former CSL dealmaking executive as a consultant to help license its Phase 3 CBD insomnia capsule internationally.